The More You Know – Support Those Who Fight For The Truth

6 Wikileaks Revelations Expose Corporate Abuse At The Expense of People & Planet

By. 

People around the world are watching as U.K. Judge Vanessa Baraitser hears arguments and decides whether or not to extradite Wikileaks Founder Julian Assange to the U.S.

While the Obama administration chose not to charge Assange, wary of the precedent it might set in criminalizing journalism, the Trump administration indicted him with 18 criminal charges that may land Assange in one of the U.S.’s most notorious prisons for 175 years.

Assange’s Wikileaks has won numerous journalism awards and has never had to retract a single publication despite releasing more than 10 million documents exposing, among other things, U.S. war crimes. Former CIA Director Leon Panetta recently indicated that the ongoing persecution of Assange is meant to “send a message to others not to do the same thing.”

As the world debates whether Assange is a hero or a traitor, Children’s Health Defense takes a step back to examine some of the things his organization has revealed for those fighting for health and environmental justice.

1. U.S. diplomatic efforts to overturn resistance to GMOs at the behest of Monsanto

Wikileaks published hundreds of diplomatic cables exhibiting attempts by the U.S. to quell opposition to genetically modified organisms or GMOs. As reported by The Guardian, “the cables show U.S. diplomats working directly for GM companies such as Monsanto.”

In a 2007 cable, Craig Stapleton, then U.S. Ambassador to France, advised the U.S. to prepare for economic war with countries unwilling to introduce Monsanto’s GM corn seeds. He recommended the U.S. “calibrate a target retaliation list that causes some pain across the E.U.”

Another dispatch, this one from 2009, demonstrated that the U.S. funded a GMO workshop in Mozambique that, according to the authors, helped advance biotech-friendly policies in the country.

In another cable from 2009, a U.S. diplomat stationed in Germany relayed intelligence on Bavarian political parties to several U.S. federal agencies and the U.S. Secretary of Defense, telling them which parties opposed Monsanto’s M810 corn seed and tactics that the U.S. could impose to resolve the opposition.

One cable from Hong Kong shows a State Department employee requesting $92,000 in U.S. public funds for “media education kits” to combat a growing popular movement calling for the labeling of GMO foods in Hong Kong. The cable indicates a desire to “make it much more difficult for mandatory labelling advocates to prevail.” The State Department’s Anita Katial, who wrote the cable, also recalled a time when her office facilitated the sending of pro-biotech and bio-agriculture DVDs to every high school in Hong Kong.

According to Food & Water Watch Executive Director Wenonah Hauter, the trove of cables “really gets down to twisting the arms of countries and working to undermine local democratic movements that may be opposed to biotech crops, and pressuring foreign governments to also reduce the oversight of biotech crops.”

2. Multinational commodities trader dumping toxic waste in West Africa

In 2006, Trafigura, the world’s second largest oil trader, illegally discharged more than 500 tons of highly toxic oil waste near the Port of Abidjan in the Ivory Coast. Some of the dump sites were near agriculture fields or water supplies, and the UN estimates that more than 100,000 people sought medical treatment due to the incident. Wikileaks would later call this incident “possibly the most culpable mass contamination incident since Bhopal.”

Trafigura’s lawyer commissioned a confidential study that listed what the environmental and health impacts of the dumping incident would be after people living near the port started flooding hospitals.

The report explained that contact with the offloaded compounds could lead to eye damage, lung damage, skin burns, headaches, breathing difficulty, permanent skin ulceration, coma and death. The report also states that the chemical compounds would have a “severe and negative effect” on the environment.

As recently as 2016, residents were complaining about the smell of the waste, headaches, breathing problems and skin problems.

Wikileaks published the classified report in 2009, the first time the public could see the company’s true negligence.

3. Gates Foundation sees environmental activists as a threat

In 2008, Bill & Melinda Gates Foundation hired an intelligence firm called Stratfor to put together a “threat assessment report” and determine current and future threats to the foundation.

Stratfor’s report saw environmental activists, indigenous farming groups, and peasant political parties in Asia and South America, as “potential threats” to the foundation.

“Threats to the foundation are likely to be directly related to the public association between the foundation and a controversial issue such as GMOs, animal testing, clinical trials and reproductive rights,” the report reads.

Stating that the primary threat to the foundation’s agriculture program comes from its work promoting GMOs, the report notes the rise of anti-GMO campaigning in developing countries, including a “staunch opposition to GMOs in India.” It even names specific activists, such as the U.S.-based anti-GMO campaigner Jeffrey Smith.

The report also mentions the work of large organizations like Greenpeace and PETA as well as alternative media outlets like the Center for Public Integrity, Mother Jones, AlterNet and the LA Times, which had just published a series accusing the foundation of “reap[ing] vast financial gains from investments in companies that contribute to the human suffering in health, housing and social welfare.”

Wikileaks published the threat assessment as part of its release of more than 5 million Stratfor emails in 2012.

4. Pharma intel and espionage operation

In 1996, Pfizer, one of the world’s largest pharmaceutical companies, conducted clinical trials in Nigeria for an antibiotic called Trovan. The results were devastating, as Nigerian officials reported more than 50 children died in the experiment and dozens became disabled.

In 2006, a Nigerian government panel concluded that Pfizer violated international law and called the experiment “an illegal trial of an unregistered drug.” In 2007, Nigerian state and federal authorities sued Pfizer for $7 billion, alleging the company did not have proper consent from the children’s parents.

A 2009 U.S. diplomatic cable published by Wikileaks revealed that while the case was in federal court, Pfizer had hired a private intelligence firm to get blackmail on Nigerian Attorney General Michael Aondoakaa.

According to the cable, “Pfizer’s investigators were passing this information to local media,” who published articles on the attorney general’s “alleged” corruption. “Aondoakaa’s cronies were pressuring him to drop the suit for fear of further negative articles,” it reads.

A few months after the negative articles, the Nigerian ministry of justice signed a settlement with Pfizer.

5. U.S. is a climate bully

Cables disclosed by Wikileaks in 2010 present the U.S. using what The Guardian called “spying, threats and promises of aid” to get international support for the 2009 Copenhagen Accord — an industry-friendly international climate deal with non-binding agreements to lower emissions. (Climate activist Naomi Klein described, at the time, the accord as “nothing more than a grubby pact between the world’s biggest emitters”.)

The State Department sent a secret cable to foreign embassies seeking human intelligence, or “dirt,” on UN diplomats regarding climate policy. And, as reported by Democracy Now!, the cables also indicated that the U.S. cut funding to Bolivia and Ecuador after both governments opposed the accord.

Bill McKibben, founder of the climate organization 350.org, said the cables exposed that “the U.S. was both bullying and buying countries into endorsing their do-little position on climate.”

6. International organizations consulting with Big Pharma

In 2009, Wikileaks revealed documents that the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) gave its members a report by the UN’s World Health Organization(WHO)’s Expert Working Group on research and development financing.

IFPMA members include pharmaceutical giants like Bayer, Johnson & Johnson, Merck, Novartis, Pfizer and Sanofi, and the organization represents these entities when dealing with the UN. What makes the Wikileaks document dump significant is that the working group gave IFPMA access to these documents months before their scheduled public release, suggesting that the UN’s health expert group was more accountable to the pharmaceutical industry than to its own member states.

“The compilation of documents shows the influence of ‘Big Pharma’ on the policy making decisions of the WHO,” Wikileaks commented when publishing the files.

Written by Jeremy Loffredo.

from:     https://www.collective-evolution.com/2020/10/06/6-wikileaks-revelations-expose-corporate-abuse-at-the-expense-of-people-planet/

Thinking About Celebrex? Check this out.

(Comment:    How about Zyflamend instead)

Pfizer ‘Cherry-Picked’ Celebrex Data, Memos Say

July 09 2012
  • New evidence in a lawsuit against Pfizer alleges that the drug company cherry-picked data on its drug Celebrex in a scheme to make the drug appear safer and more effective than it really is
  • Pfizer withheld critical data needed to assess the drug’s effectiveness, and newly unsealed documents showed this was all what appeared to be part of a carefully calculated plan by Pfizer execs
  • On a regular basis new studies appear that show the real risks of many medications, including popular varieties that are used by millions of people
  • The number of lawsuits that Big Pharma is settling―many of them out of court without going to trial―are rising, with settlement amounts in the billions
  • If you are still under the impression that drugs are the “answer” to your health complaints, you are likely being misled … and may be worsening your health by the day

By Dr. Mercola

Celebrex is a type of nonsteroidal anti-inflammatory drug (NSAID) known as a COX-2 inhibitor.

Basically, it works by blocking COX-2 enzymes, which become overly active in your body when it becomes inflamed, and is widely used as a form of pain relief; in 2011, 2.4 million Americans received prescriptions for this drug.i

They may have thought twice, however, if they knew the truth behind how this drug came to be … a story that involves cherry-picking of data in attempts to make the drug seem superior to others on the market, when in fact it was not.

Also concerning: Celebrex is the only selective COX-2 inhibitor left on the market, as its close “cousins” were all pulled due to either their killing tens of thousands of people or to their unacceptably high heart risks …

Internal Memos Reveal Deception Surrounding Celebrex Data

New evidence in a lawsuit against Pfizer alleges that the drug company cherry-picked data on its drug Celebrex. Its claim to fame when it came on the market in 1998 was that it relieved pain without causing the gastrointestinal side effects common to other pain-relief drugs like ibuprofen.

Studies showed it didn’t necessarily relieve pain any better than the other drugs on the market, so Pfizer was counting on the gastrointestinal “ticket” to propel the drug into blockbuster status, and, in fact, used its easiness on your stomach as its primary selling point.

The problem was, Celebrex only appeared to be easier on the stomach because Pfizer, and its partner Pharmacia, only released the first six months of data from a year-long study. When the entire data set was looked at, the stomach “benefit” disappeared.

Folks this is what is called a blatant lie of omission and these companies do it on a regular basis. The system even encourages it. Contrary to what many people believe the FDA does no testing of drugs that are to be approved. Nor is there an objective third party that does tests. Rather the system the FDA employs has the drug company pay for and do the studies, and they only submit the studies that support the release of their drug. They are not required to submit failed ones.

That Pfizer withheld the critical data has been known for years, but newly unsealed documents showed this was all part of a carefully calculated plan by Pfizer and Pharmacia execs. While medical directors and scientists at the company expressed feeling uncomfortable with the “data massaging” and “cherry picking” of data, the powers that be moved full steam ahead with their deceptive marketing blitz.

Another reason that you might not be surprised about this report is that Pfizer purchased Monsanto and spun it off as subsidiary called Pharmacia in 1997.ii Most readers of this newsletter will instantly recognize that the bastion of evil, Monsanto, would not be out of place with this type of behavior.

The New York Times reported:iii

“The documents suggest that officials made a strategic decision during the early trial to be less than forthcoming about the drug’s safety. They show that executives considered attacking the trial’s design before they even knew the results and disregarded the advice of an employee and an outside consultant who had argued the companies should disclose the fact that they were using incomplete data.

… The documents show that in February 2000, Pharmacia employees came up with a game plan on how they might present the findings once they were available … Another document, a slide, proposed explaining poor results through “statistical glitches.””

Do You Still Trust Celebrex?

Celebrex is still being widely used, often by arthritis patients who are desperate for pain relief. But even if you overlook the fact that it’s made by a company that clearly puts profits ahead of patients, it’s much harder to shrug off the very real risks it poses to your heart.

Remember, Celebrex is in the same class of drugs as Vioxx and Bextra, both of which were pulled from the market because of serious heart risks or killing tens of thousands of people. Celebrex may still be on the market, but it is not immune to these risks!

In 2006, the New England Journal of Medicine released a study that discussed “a significant increase in adjudicated serious cardiovascular events with the use of celecoxib [Celebrex] … an increase in risk by a factor of two or three for … myocardial infarction, stroke, congestive heart failure, or cardiovascular-related death.” The risk was so severe that it “prompted suspension of the administration of celecoxib …”iv

Pfizer actually has a trial that’s ongoing right now that’s supposed to compare the heart risks of Celebrex to those of ibuprofen (Advil/Motrin) and naproxen (Aleve). But though it was started in 2005, it’s not slated to be completed until 2014 … the same year the Celebrex patent expires (at which point the company’s profits for the drug will dwindle … making negative study results far less impacting).

It’s widely known, however, that this painkiller has been linked to increased risks of stomach bleeding, kidney trouble, and liver damage – along with other adverse reactions that can range from mild to deadly. And it’s not at all unusual for a drug company to play up the “fabulous benefits” of their products while conveniently glossing over the fatalities they’ve caused … what would be unusual is if they didn’t.

Common Diabetes Drugs Associated with Increased Risk of Death

New studies regularly reveal the true risks of many medications, including popular varieties that are used by millions of people. For example, an analysis of nearly 24,000 patients with type 2 diabetes found that three diabetes drugs — glipizide, glyburide, and glimepiride – caused a more than 50 percent greater risk of death compared to another diabetes drug, Metformin.v The three drugs are known as sulfonylureas, which work by spurring your body to produce more insulin.

The drugs not only increased the risk of death among all patients, but among those with heart disease (which is common among those with diabetes), glipizide increased the risk of death by 41 percent, and glyburide by 38 percent compared to Metformin.

But simply switching to metformin, a drug that makes your body’s tissues more sensitive to insulin, is not the answer here, as type 2 diabetes can be effectively treated without medications in the vast majority of cases. In fact, drugs can’t cure diabetes, as they do nothing to address the underlying cause. To learn about the drug-free methods that can prevent, and reverse, diabetes, we published a report on this last month.

to read more, go to:    http://articles.mercola.com/sites/articles/archive/2012/07/09/lawsuit-against-pfizer-celebrex.aspx?e_cid=20120709_DNL_artNew_2